Literature DB >> 28636205

Progressive SCAR14 with unclear speech, developmental delay, tremor, and behavioral problems caused by a homozygous deletion of the SPTBN2 pleckstrin homology domain.

Esra Yıldız Bölükbaşı1, Muhammad Afzal2, Sara Mumtaz2, Nafees Ahmad3, Sajid Malik2, Aslıhan Tolun1.   

Abstract

We report on nine members of a consanguineous Pakistani family with primary presentation of intellectual disability, developmental delay, limb and gait ataxia, behavioral and speech problems, and tremor. By linkage mapping and exome sequencing we identified novel homozygous splicing variant c.6375-1G>C in SPTBN2. To date, only two other SPTBN2 mutations with recessive pattern of inheritance causing SCAR14 (spinocerebellar ataxia, autosomal recessive 14) that manifest with developmental ataxia and cognitive impairment, or cerebellar ataxia, mental retardation, and pyramidal signs have been reported. The mutation we identified is predicted to lead to the deletion of just the pleckstrin homology domain; thus, the earlier onset and more progressive nature of the disease in the presented family, as compared to earlier reports, were unexpected. No other mutation that could possibly explain the features that were unusual for SCAR14-arched palate, limb hypotonia, climacophobia, and behavioral problems-was identified. The disease was more severe in males than females. Our findings expand the recessive SPTBN2 mutation phenotype. We also review SPTBN2 mutation phenotypes. The gene encodes beta-III spectrin, which forms tetramers with alpha-II spectrin. The manifestations of this third recessive mutation suggest that for recessive mutations either no mutant protein is synthesized because the transcript is subject to nonsense-mediated decay or the mutant protein does not bind membrane proteins and, thus, does not exert a negative effect in heterozygotes, whereas the dominant mutations causing SCA5 form defective tetramers that compete with the native tetramers in binding membrane proteins, but are unable to anchor them.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Pakistani family; SPTBN2; cerebellar ataxia; developmental delay; intellectual disability; spinocerebellar ataxia

Mesh:

Substances:

Year:  2017        PMID: 28636205     DOI: 10.1002/ajmg.a.38332

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  Between SCA5 and SCAR14: delineation of the SPTBN2 p.R480W-associated phenotype.

Authors:  Sara Nuovo; Alessia Micalizzi; Stefano D'Arrigo; Monia Ginevrino; Tommaso Biagini; Tommaso Mazza; Enza Maria Valente
Journal:  Eur J Hum Genet       Date:  2018-05-25       Impact factor: 4.246

2.  Highly efficient manipulation of nervous system gene expression with NEPTUNE.

Authors:  Katrin Mangold; Jan Mašek; Jingyan He; Urban Lendahl; Elaine Fuchs; Emma R Andersson
Journal:  Cell Rep Methods       Date:  2021-07-06

3.  The Spread of Spectrin in Ataxia and Neurodegenerative Disease.

Authors:  Jon S Morrow; Michael C Stankewich
Journal:  J Exp Neurol       Date:  2021

Review 4.  A Novel Homozygous Mutation in SPTBN2 Leads to Spinocerebellar Ataxia in a Consanguineous Family: Report of a New Infantile-Onset Case and Brief Review of the Literature.

Authors:  Mohammad A Al-Muhaizea; Faten AlMutairi; Rawan Almass; Safinaz AlHarthi; Mazhor S Aldosary; Maysoon Alsagob; Ali AlOdaib; Dilek Colak; Namik Kaya
Journal:  Cerebellum       Date:  2018-06       Impact factor: 3.847

Review 5.  The Classification of Autosomal Recessive Cerebellar Ataxias: a Consensus Statement from the Society for Research on the Cerebellum and Ataxias Task Force.

Authors:  Marie Beaudin; Antoni Matilla-Dueñas; Bing-Weng Soong; Jose Luiz Pedroso; Orlando G Barsottini; Hiroshi Mitoma; Shoji Tsuji; Jeremy D Schmahmann; Mario Manto; Guy A Rouleau; Christopher Klein; Nicolas Dupre
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

6.  DNA Methylation in LIME1 and SPTBN2 Genes Is Associated with Attention Deficit in Children.

Authors:  Sung-Chou Li; Ho-Chang Kuo; Lien-Hung Huang; Wen-Jiun Chou; Sheng-Yu Lee; Wen-Ching Chan; Liang-Jen Wang
Journal:  Children (Basel)       Date:  2021-01-29

7.  A Comprehensive Analysis of the Downregulation of miRNA-1827 and Its Prognostic Significance by Targeting SPTBN2 and BCL2L1 in Ovarian Cancer.

Authors:  Penghui Feng; Zhitong Ge; Zaixin Guo; Lin Lin; Qi Yu
Journal:  Front Mol Biosci       Date:  2021-06-11

8.  Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.

Authors:  Margot A Cousin; Blake A Creighton; Keith A Breau; Rebecca C Spillmann; Erin Torti; Sruthi Dontu; Swarnendu Tripathi; Deepa Ajit; Reginald J Edwards; Simone Afriyie; Julia C Bay; Kathryn M Harper; Alvaro A Beltran; Lorena J Munoz; Liset Falcon Rodriguez; Michael C Stankewich; Richard E Person; Yue Si; Elizabeth A Normand; Amy Blevins; Alison S May; Louise Bier; Vimla Aggarwal; Grazia M S Mancini; Marjon A van Slegtenhorst; Kirsten Cremer; Jessica Becker; Hartmut Engels; Stefan Aretz; Jennifer J MacKenzie; Eva Brilstra; Koen L I van Gassen; Richard H van Jaarsveld; Renske Oegema; Gretchen M Parsons; Paul Mark; Ingo Helbig; Sarah E McKeown; Robert Stratton; Benjamin Cogne; Bertrand Isidor; Pilar Cacheiro; Damian Smedley; Helen V Firth; Tatjana Bierhals; Katja Kloth; Deike Weiss; Cecilia Fairley; Joseph T Shieh; Amy Kritzer; Parul Jayakar; Evangeline Kurtz-Nelson; Raphael A Bernier; Tianyun Wang; Evan E Eichler; Ingrid M B H van de Laar; Allyn McConkie-Rosell; Marie T McDonald; Jennifer Kemppainen; Brendan C Lanpher; Laura E Schultz-Rogers; Lauren B Gunderson; Pavel N Pichurin; Grace Yoon; Michael Zech; Robert Jech; Juliane Winkelmann; Adriana S Beltran; Michael T Zimmermann; Brenda Temple; Sheryl S Moy; Eric W Klee; Queenie K-G Tan; Damaris N Lorenzo
Journal:  Nat Genet       Date:  2021-07-01       Impact factor: 41.307

9.  An Apoptosis-Related Gene Prognostic Index for Colon Cancer.

Authors:  Hanmin Tang; Jing Wang; Xuehui Luo; Qi Wang; Jie Chen; Xinyue Zhang; Qiuting Li; Chengyi Gao; Yuesen Li; Suxia Han
Journal:  Front Cell Dev Biol       Date:  2021-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.